Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Single‐Center Double‐Blinded Randomized Trial

Background Remote ischemic preconditioning (RIPC) harnesses an innate defensive mechanism that protects against inflammatory activation and ischemia‐reperfusion injury, known sequelae of cardiac surgery with cardiopulmonary bypass. We sought to determine the impact of RIPC on clinical outcomes and p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Heart Association 2014-07, Vol.3 (4), p.n/a
Main Authors: McCrindle, Brian W., Clarizia, Nadia A., Khaikin, Svetlana, Holtby, Helen M., Manlhiot, Cedric, Schwartz, Steven M., Caldarone, Christopher A., Coles, John G., Van Arsdell, Glen S., Scherer, Stephen W., Redington, Andrew N.
Format: Article
Language:English
Subjects:
Adolescent
Cardiac Surgical Procedures - methods
Cardiopulmonary Bypass - methods
Child
Child, Preschool
congenital
Double-Blind Method
Female
heart defects
Humans
Infant
Infant, Newborn
Inflammation - prevention & control
Ischemic Preconditioning - methods
Length of Stay
Lower Extremity - blood supply
Male
Myocardial Reperfusion Injury - prevention & control
Original Research
pediatrics
remote ischemic preconditioning
surgery
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Remote ischemic preconditioning (RIPC) harnesses an innate defensive mechanism that protects against inflammatory activation and ischemia‐reperfusion injury, known sequelae of cardiac surgery with cardiopulmonary bypass. We sought to determine the impact of RIPC on clinical outcomes and physiological markers related to ischemia‐reperfusion injury and inflammatory activation after cardiac surgery in children. Methods and Results Overall, 299 children (aged neonate to 17 years) were randomized to receive an RIPC stimulus (inflation of a blood pressure cuff on the left thigh to 15 mm Hg above systolic for four 5‐minute intervals) versus a blinded sham stimulus during induction with a standardized anesthesia protocol. Primary outcome was duration of postoperative hospital stay, with serial clinical and laboratory measurements for the first 48 postoperative hours and clinical follow‐up to discharge. There were no significant baseline differences between RIPC (n=148) and sham (n=151). There were no in‐hospital deaths. No significant difference in length of postoperative hospital stay was noted (sham 5.4 versus RIPC 5.6 days; difference +0.2; adjusted P=0.91), with the 95% confidence interval (−0.7 to +0.9) excluding a prespecified minimal clinically significant differences of 1 or 1.5 days. There were few significant differences in other clinical outcomes or values at time points or trends in physiological markers. Benefit was not observed in specific subgroups when explored through interactions with categories of age, sex, surgery type, Aristotle score, or first versus second half of recruitment. Adverse events were similar (sham 5%, RIPC 6%; P=0.68). Conclusions RIPC is not associated with important improvements in clinical outcomes and physiological markers after cardiac surgery in children. Clinical Trial Registration URL: clinicaltrials.gov. Unique identifier: NCT00650507.
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.114.000964